María Ángeles Vaz-Salgado

7PUBLICATIONS
26CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 05, 2026
Management of glioblastoma in the elderly.

|Dec 04, 2025
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.

María Ángeles Vaz-Salgado, Sonia Del Barco, Juan Manuel Sepúlveda

|Oct 20, 2025
Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteria.

Maria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl

|Aug 04, 2025
Oligodendrogliomas: findings after classifying the same cohort using pre- and post-World Health Organization (WHO) 2021 criteria.

Maria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl

|Apr 25, 2024
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).

María Ángeles Vaz-Salgado, Belén Cigarral García, Isaura Fernández Pérez

|Jun 06, 2022
Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot study.

María Angeles Vaz Salgado, Julie Earl, Victor Rodriguez Berrocal

Pageof 2

Frequent Collaborators

3 joint publications

Julie Earl

2 joint publications

Carmen Balana

2 joint publications

Juan Manuel Sepulveda-Sanchez

2 joint publications

Sonia Del Barco